Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Clinical epigenetics: seizing opportunities for translation
by
Berdasco, María
, Esteller, Manel
in
Biomarkers
/ Epigenetics
/ Immune system
/ Infectious diseases
/ Oncology
2019
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Clinical epigenetics: seizing opportunities for translation
by
Berdasco, María
, Esteller, Manel
in
Biomarkers
/ Epigenetics
/ Immune system
/ Infectious diseases
/ Oncology
2019
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Clinical epigenetics: seizing opportunities for translation
Journal Article
Clinical epigenetics: seizing opportunities for translation
2019
Request Book From Autostore
and Choose the Collection Method
Overview
Biomarker discovery and validation are necessary for improving the prediction of clinical outcomes and patient monitoring. Despite considerable interest in biomarker discovery and development, improvements in the range and quality of biomarkers are still needed. The main challenge is how to integrate preclinical data to obtain a reliable biomarker that can be measured with acceptable costs in routine clinical practice. Epigenetic alterations are already being incorporated as valuable candidates in the biomarker field. Furthermore, their reversible nature offers a promising opportunity to ameliorate disease symptoms by using epigenetic-based therapy. Thus, beyond helping to understand disease biology, clinical epigenetics is being incorporated into patient management in oncology, as well as being explored for clinical applicability for other human pathologies such as neurological and infectious diseases and immune system disorders.
Publisher
Nature Publishing Group
Subject
This website uses cookies to ensure you get the best experience on our website.